» Authors » Elena G Hughes

Elena G Hughes

Explore the profile of Elena G Hughes including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 12
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ngo S, Hu T, Zhu C, Hughes E, Mao Y, Yeh M, et al.
Surgery . 2025 Feb; 181:109160. PMID: 39938126
Background: The utility of prophylactic ipsilateral central neck dissection in papillary thyroid carcinoma presenting with clinically/sonographically apparent lymph node metastases isolated to the lateral neck is unclear. The study assessed...
2.
Huston-Paterson H, Mao Y, Hughes E, Bobanga I, Wu J, Yeh M
Am Surg . 2024 Dec; :31348241307399. PMID: 39659103
Background: Patients residing in rural and frontier areas experience worse thyroid cancer outcomes than those in urban areas. This novel qualitative study sought the perspectives of rural surgeons to identify...
3.
Seo Y, Huston-Paterson H, Schumm M, Longstaff X, Hughes E, Tseng C, et al.
Endocr Pract . 2024 Dec; 31(3):366-372. PMID: 39647526
Objective: Although thyroid tumors possessing isolated RAS mutations are generally considered to be indolent, the oncologic outcomes of tumors evaluated with comprehensive molecular testing have not been well characterized. Methods:...
4.
Ahmadi S, Kotwal A, Bikas A, Xiang P, Goldner W, Patel A, et al.
J Clin Endocrinol Metab . 2024 Feb; 109(12):e2231-e2239. PMID: 38415829
Context: Molecular testing can refine the risk of malignancy in thyroid nodules with indeterminate cytology to decrease unnecessary diagnostic surgery. Objective: This study was performed to evaluate the outcomes of...
5.
Mao Y, Hughes E, Steinmetz D, Troob S, Kim J, Tseng C, et al.
JAMA Otolaryngol Head Neck Surg . 2024 Jan; 150(3):209-214. PMID: 38270925
Importance: Standard treatment for patients with medullary thyroid cancer (MTC) consists of total thyroidectomy with central neck dissection, but the rationale for bilateral surgery in patients with unilateral disease on...
6.
Raghunathan R, Longstaff X, Hughes E, Li S, Sant V, Tseng C, et al.
Surgery . 2023 Nov; 175(1):221-227. PMID: 37926582
Background: Indeterminate thyroid nodules with Hürthle cell cytology remain a diagnostic challenge. The low benign call rate and positive predictive value of first-generation molecular tests precluded their use to rule...
7.
Schumm M, Shu M, Hughes E, Nikiforov Y, Nikiforova M, Wald A, et al.
JAMA Otolaryngol Head Neck Surg . 2023 Jun; 149(8):735-742. PMID: 37382944
Importance: Molecular testing is commonly used in the diagnosis of thyroid nodules with indeterminate cytology. The role of molecular testing in prognosticating oncologic outcomes in thyroid nodules with suspicious or...
8.
Kim N, Raghunathan R, Hughes E, Longstaff X, Tseng C, Li S, et al.
J Clin Endocrinol Metab . 2023 Mar; 108(9):e698-e703. PMID: 36995878
Context: Molecular testing has improved risk stratification and increased nonoperative management for patients with indeterminate thyroid nodules, but data on the long-term outcomes of current molecular tests Afirma Gene Sequencing...